[1] |
Morra M.Engineering of biomaterials surfaces by hyaluronan[J]. Biomacromolecules,2005,6(3):1 205-23.
|
[2] |
Stern R,Asari AA,Sugahara KN.Hyaluronan fragments:an information-rich system[J]. Eur J Cell Biol,2006,85(8):699-715.
|
[3] |
Gerecht S,Burdick JA,Ferreira LS,et al.Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells[J]. Proc Natl Acad Sci USA,2007,104(27):11 298-11 303.
|
[4] |
Yu Q,Toole BP,Stamenkovic I.Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function[J]. J Exp Med,1997,186(12):1 985-1 996.
|
[5] |
Yasuda M,Tanaka Y,Fujii K,et al.CD44 stimulation down regulates Fas expression and Fas mediated apoptosis of lung cancer cells[J].Int Immunol,2001,13(10):1 309-1 319.
|
[6] |
Wang YZ,Cao ML,Liu YW,et al.CD44 mediates oligosaccharides of hyaluronan-induced proliferation,tube formation and signal transduction in endothelial cells[J]. Exp Biol Med,2011,236(1):84-90.
|
[7] |
Yang C,Cao M,Liu H,et al.The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering[J]. J Biol Chem,2012,287(51):43 094-43 107.
|
[8] |
Toole BP.Hyaluronan:from extracellular glue to pericellular cue[J]. Nat Rev Cancer,2004,4(7):528-539.
|
[9] |
Jaracz S,Chen J,Kuznetsova LV,et al.Recent advances in tumor-targeting anticancer drug conjugates[J]. Bioorg Med Chem,2005,13(17):5 043-5 054.
|
[10] |
Götte M,Yip GW.Heparanase,hyaluronan,and CD44 in cancers:a breast carcinoma perspective[J].Cancer Res,2006,66(21):10 233-10 237.
|
[11] |
Choi KY,Min KH,Yoon HY,et al.PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo[J]. Biomaterials,2011,32(7):1 880-1 889.
|
[12] |
Heffernan MJ,Murthy N.Polyketal nanoparticles:a new pH-sensitive biodegradable drug delivery vehicle[J].Bioconjug Chem,2005,16(6):1 340-1 342.
|